1 results match your criteria: "KOLderma Clinical Trials Institute - Kosmoscience Group[Affiliation]"
Int J Dermatol
July 2017
KOLderma Clinical Trials Institute - Kosmoscience Group, Campinas, SP, Brazil.
Background: Pollution, especially cigarette smoke, is a major cause of skin damage.
Objectives: To assess the effects of the small molecule polyphenol, honokiol, on reversing cigarette smoke-induced damage in vitro to relevant skin cells.
Methods: Keratinocytes (HaCat) cultures were exposed to cigarette smoke and, after 48 hours, IL-1α and IL-8 were measured in cell supernatants.